*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
T461X5A - Adverse effect of calcium-channel blockers, initial encounter - as a primary diagnosis code | T461X5A - Adverse effect of calcium-channel blockers, initial encounter - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 4.76 | |
Readmission Rate (%) | 19.88 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 71,748 | |
Total Hospitalizations with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 33 | |
DRG Share of Total Hospitalizations | 0.22 | |
% of Total ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter in DRG | 64.71 | |
Avg LOS at DRG | 2.93 | |
Avg LOS with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 2.61 | |
Readmission Rate at DRG | 33.86 | |
Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | |
Unplanned Readmission Rate at DRG | 10.34 | |
Unplanned Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | |
Total Medicare payments at DRG | $313,351,773 | |
Total Medicare payments with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $126,834 | |
Total Medicare payment per Day at DRG | $1,489 | |
Total Medicare payment per Day with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $1,475 | |
Total Medicare payment per Hospitalization at DRG | $4,367 | |
Total Medicare payment per Hospitalization with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $3,843 | |
Total Medicare Charges at DRG | $1,750,048,705 | |
Total Medicare Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $557,577 | |
Avg Charges at DRG | $24,392 | |
Avg Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $16,896 | |
Mortality Rate at DRG | 0.22 | |
Mortality Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | |
SNF Discharge Rate at DRG | 7.61 | |
SNF Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | |
Home Discharge Rate at DRG | 51.88 | |
Home Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 75.76 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 292,335 | ||||
Total Hospitalizations with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 2,988 | ||||
DRG Share of Total Hospitalizations | 0.89 | ||||
% of Total ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter in DRG | 12.72 | ||||
Avg LOS at DRG | 2.96 | ||||
Avg LOS with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 2.98 | ||||
Readmission Rate at DRG | 19.18 | ||||
Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 16.61 | ||||
Unplanned Readmission Rate at DRG | 13.96 | ||||
Unplanned Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 12.7 | ||||
Total Medicare payments at DRG | $1,347,436,356 | ||||
Total Medicare payments with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $13,818,194 | ||||
Total Medicare payment per Day at DRG | $1,557 | ||||
Total Medicare payment per Day with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $1,550 | ||||
Total Medicare payment per Hospitalization at DRG | $4,609 | ||||
Total Medicare payment per Hospitalization with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $4,625 | ||||
Total Medicare Charges at DRG | $7,385,462,160 | ||||
Total Medicare Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $74,976,593 | ||||
Avg Charges at DRG | $25,264 | ||||
Avg Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $25,093 | ||||
Mortality Rate at DRG | 0.57 | ||||
Mortality Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 11.55 | ||||
SNF Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 12.78 | ||||
Home Discharge Rate at DRG | 63.79 | ||||
Home Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 60.94 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,808,415 | ||||
Total Hospitalizations with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 703 | ||||
DRG Share of Total Hospitalizations | 5.5 | ||||
% of Total ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter in DRG | 2.99 | ||||
Avg LOS at DRG | 6.34 | ||||
Avg LOS with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 6.84 | ||||
Readmission Rate at DRG | 24.2 | ||||
Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 22.02 | ||||
Unplanned Readmission Rate at DRG | 16.78 | ||||
Unplanned Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 16.48 | ||||
Total Medicare payments at DRG | $21,288,214,047 | ||||
Total Medicare payments with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $8,179,272 | ||||
Total Medicare payment per Day at DRG | $1,857 | ||||
Total Medicare payment per Day with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $1,700 | ||||
Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
Total Medicare payment per Hospitalization with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $11,635 | ||||
Total Medicare Charges at DRG | $107,155,481,388 | ||||
Total Medicare Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $44,194,126 | ||||
Avg Charges at DRG | $59,254 | ||||
Avg Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $62,865 | ||||
Mortality Rate at DRG | 12.11 | ||||
Mortality Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 7.25 | ||||
SNF Discharge Rate at DRG | 27.18 | ||||
SNF Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 32.15 | ||||
Home Discharge Rate at DRG | 25.81 | ||||
Home Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 24.89 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 160,950 | ||||
Total Hospitalizations with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 278 | ||||
DRG Share of Total Hospitalizations | 0.49 | ||||
% of Total ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter in DRG | 1.18 | ||||
Avg LOS at DRG | 4.98 | ||||
Avg LOS with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 2.86 | ||||
Readmission Rate at DRG | 20.85 | ||||
Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 17.34 | ||||
Unplanned Readmission Rate at DRG | 13.4 | ||||
Unplanned Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 12.92 | ||||
Total Medicare payments at DRG | $1,184,949,733 | ||||
Total Medicare payments with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $1,343,061 | ||||
Total Medicare payment per Day at DRG | $1,477 | ||||
Total Medicare payment per Day with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $1,692 | ||||
Total Medicare payment per Hospitalization at DRG | $7,362 | ||||
Total Medicare payment per Hospitalization with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $4,831 | ||||
Total Medicare Charges at DRG | $4,222,078,897 | ||||
Total Medicare Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $6,946,334 | ||||
Avg Charges at DRG | $26,232 | ||||
Avg Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $24,987 | ||||
Mortality Rate at DRG | 0.67 | ||||
Mortality Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 22.29 | ||||
SNF Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 15.11 | ||||
Home Discharge Rate at DRG | 35.46 | ||||
Home Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 56.83 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 250,159 | ||||
Total Hospitalizations with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 216 | ||||
DRG Share of Total Hospitalizations | 0.76 | ||||
% of Total ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter in DRG | 0.92 | ||||
Avg LOS at DRG | 5.47 | ||||
Avg LOS with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 5.61 | ||||
Readmission Rate at DRG | 27.88 | ||||
Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 35.11 | ||||
Unplanned Readmission Rate at DRG | 19.94 | ||||
Unplanned Readmission Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 24.47 | ||||
Total Medicare payments at DRG | $2,661,443,545 | ||||
Total Medicare payments with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $2,252,681 | ||||
Total Medicare payment per Day at DRG | $1,946 | ||||
Total Medicare payment per Day with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $1,860 | ||||
Total Medicare payment per Hospitalization at DRG | $10,639 | ||||
Total Medicare payment per Hospitalization with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $10,429 | ||||
Total Medicare Charges at DRG | $13,270,497,724 | ||||
Total Medicare Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $11,254,105 | ||||
Avg Charges at DRG | $53,048 | ||||
Avg Charges with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | $52,102 | ||||
Mortality Rate at DRG | NA | ||||
Mortality Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 21.63 | ||||
SNF Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 21.3 | ||||
Home Discharge Rate at DRG | 34.87 | ||||
Home Discharge Rate with ICD T461X5A - Adverse effect of calcium-channel blockers, initial encounter | 35.65 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
SOUTH SHORE HOSPITAL | 55 FOGG ROAD | SOUTH WEYMOUTH | MA | 02190 | 86 |
BEAUMONT HOSPITAL ROYAL OAK | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073 | 70 |
ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 63 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. MORAD L EL-RAHEB | 1145 S UTICA AVE | TULSA | OK | 74104 | 12 |